DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.07% to $635.45 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 2.64% to 7,383.74 and Dow Jones Industrial Average falling 1.35% to 50,866.78.
This was the stock's fourth consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 22.61% short of its 52-week high of $821.11, which the company reached on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.15% to $349.58, Moderna Inc. (MRNA) fell 8.04% to $47.44, and Gilead Sciences Inc. (GILD) fell 0.02% to $129.16.
Trading volume (975,387) eclipsed its 50-day average volume of 898,755.
Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 05, 2026 16:46 ET (20:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments